Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827632 · ClinicalTrials.gov registry record · Phase 4
Obesity, Oral Contraception, and Ovarian Suppression
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 226
- Enrollment target
NCT00827632 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 226 participants.
The verdict
NCT00827632, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 226 participants
- Enrollment target
Study Summary
This study proposes a double blind randomized clinical trial to include normal weight and obese women who have normal ovulatory function at baseline; the investigators will randomize women to 2 widely used OCs and evaluate ovarian follicle development and circulating progesterone to assess ovarian suppression during OC use.
Interventions
- DRUG Low dose formulation
- DRUG High dose formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00827632
The ClinicalTrials.gov registry entry for NCT00827632 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low dose formulation is the first listed.
NCT00827632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00827632 about?
NCT00827632 is a clinical study titled "Obesity, Oral Contraception, and Ovarian Suppression". This study proposes a double blind randomized clinical trial to include normal weight and obese women who have normal ovulatory function at baseline; the investigators will randomize women to 2 widely used OCs and evaluate ovarian follicle development and circulating progesterone to assess ovarian s...
What is the current status of trial NCT00827632?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 226 participants. The study started on 2006-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00827632?
The interventions under investigation include: Low dose formulation (DRUG), High dose formulation (DRUG).
Who is sponsoring clinical trial NCT00827632?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.